Evidence map›Paper›PMID 38339285›Full record

ArticleCancers2024

Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy.

Gunnar Lohm, Franz Knörnschild, Konrad Neumann, Volker Budach, Stefan Schwartz, Susen Burock, Dirk Böhmer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Gunnar LohmDepartment of Radiation Oncology, Johanniter-Hospital Genthin-Stendal, 39576 Stendal, Germany.
Franz KnörnschildDepartment of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Konrad NeumannInstitute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0001-9482-0971
Volker BudachRadiation Oncology Vosspalais, Private Clinic, Voss-St. 44, 10177 Berlin, Germany.
Stefan SchwartzDepartment of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0001-8833-5793
Susen BurockClinical Trial Office (Campus Mitte), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Dirk BöhmerDepartment of Radiation Oncology (Campus Benjamin Franklin), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0001-9285-6591
Charité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DEGerman Cancer Research Center · DEZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In patients with prostate cancer (PCa), salvage radiotherapy (SRT) for biochemical progression (BP) after radical prostatectomy (RP) improves PCa-specific survival. However, no prospective randomized trials have compared the effect of SRT with untreated patients. In this analysis of 151 patients who received SRT for post-RP BP, we compared their overall survival (OS) with virtual, age-matched controls (

Indexed as

biochemical relapseoverall survivalprostate cancerPSA doubling timesalvage radiotherapy

Identifiers

PMID38339285
PMCPMC10854858
OpenAlexW4391251954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.